TY - CHAP T1 - MRSA in urology T2 - Urogenital Infections and Inflammations AU - Takahashi, Satoshi ED - Naber, Kurt G. AD - Satoshi Takahashi, Sapporo Medical University School of Medicine, Department of Infection Control and Laboratory Medicine, -, Sapporo, Japan, Phone: -, E-mail: stakahas@sapmed.ac.jp N2 - Methicillin-resistant Staphylococcus aureus (MRSA) is the main pathogen in healthcare-associated infections (HAI) worldwide, especially in hospitals and long-term care facilities. In the field of urology, however, there is a lack of comprehensive studies on MRSA infections. Therefore, urological infections caused by MRSA need to be examined more carefully in clinical trials, because urinary tract infections (UTI) and surgical site infections (SSI) caused by MRSA are both important HAI. Treatment of MRSA infection is usually empirical, but complete eradication of MRSA from the urinary tract is difficult because of complicating factors, such as indwelling catheters. There have been, however, no randomized clinical trials on treatment of the various MRSA infections in urological diseases to date. In recent years, community-associated MRSA (CA-MRSA) has been noted as an emerging pathogen causing SSI in the community. Therefore, we should know how to diagnose and treat such SSI caused by CA-MRSA, although they have been rare in the field of urology. PY - 2018 DA - 2018/10/05 DO - 10.5680/lhuii000042 LA - en L1 - https://books.publisso.de/en/system/getFile/702 UR - https://dx.doi.org/10.5680/lhuii000042 L2 - https://dx.doi.org/10.5680/lhuii000042 KW - methicillin-resistant S. aureus (MRSA) KW - urology KW - urinary tract infection KW - surgical site infection PB - German Medical Science GMS Publishing House CY - Berlin ER -